Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India, says GlobalData
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
Ayurveda is one of the most advanced sciences of its times
This artificial RNA ligase has higher thermostability than natural RNA ligase
The partnership is announced at Aero India 2023, Bangalore
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Subscribe To Our Newsletter & Stay Updated